PHARMAFILE – LIVING WITH A RARE CHROMOSOME DISORDER

Rebecca Pender’s daughter Hannah lives with the ultra-rare condition Inv Dup Del 8p, a genetic arrangement that affects just 80 people worldwide. She recounts the struggle to secure a diagnosis, and how the experience shaped her attitude on how we confront rare disease.

Can you shed some light on the nature of Inv Dup Del 8p?

Inv Dup Del 8p stands for ‘inverted duplication and deletion on the short arm of chromosome 8’. It doesn’t have an eponymous name. My daughter is literally missing some genetic material, and also has some other genetic material doubled up, on her eighth chromosome. There are only 80 people in the world that have this condition, most of whom are children.

Up until the beginning of February there were only 65, and then the UNIQUE database was updated so now we now know of 80 people with the condition. Most families know each other quite well – we’re all in contact with each other and there’s a huge [sense of] community because it’s so rare that, 90% of the time, [the doctors you come across have] never heard about and don’t know anything about it. We have had to become expert patients.

CONTINUE READING

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.
  • Lead with knowledge from patients. Currently, there is no cure for 8p disorders, nor is there a standard course of treatment.

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Raise transformative funding for pioneering scientific research into treatments for a complex, rare disease involving 250+ affected genes on the short arm of the 8 th chromosome (8p). Rearrangements of these genes causes significant abnormalities to the entire neurological system, thus all organs and functions of the body– with variance in cognitive functions, gross motor skills, social development and other challenges during infancy, and throughout life;
  • Empower a unified community of 8p patients and their families so they can have meaningful lives today; and
  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.